Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2

Repurposing clinically available drugs to treat the new coronavirus disease 2019 (COVID-19) is an urgent need in the course of the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) pandemic, as very few treatment options are available. The iminosugar Miglustat is a well-characterized drug f...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajasekharan, Sreejith, Milan Bonotto, Rafaela, Nascimento Alves, Lais, Kazungu, Yvette, Poggianella, Monica, Martinez-Orellana, Pamela, Skoko, Natasa, Polez, Sulena, Marcello, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144969/
https://www.ncbi.nlm.nih.gov/pubmed/33946304
http://dx.doi.org/10.3390/v13050808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144969/
https://www.ncbi.nlm.nih.gov/pubmed/33946304
http://dx.doi.org/10.3390/v13050808

Ejemplares similares